High-stability multifunctional hemostatic gauze with fibers compounded with aluminum minerals and preparation method of high-stability multifunctional hemostatic gauze
By using a solution containing X cations and a suspension of aluminum-based mineral or aluminum-based mineral composite materials and sodium alginate in the gauze for hot rolling, the stable cross-linking network structure is strengthened, and the hemostatic activity of kaolin-based hemostatic gauze is solved. The problem of component peeling improves the stability and antibacterial effect of the gauze.
Patent Information
- Application Number
- CN202410950533.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-16
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2044-07-16
AI Technical Summary
The existing kaolin-based hemostatic gauze is prone to falling off during use, resulting in side effects such as inflammation and thrombosis, and poses safety hazards.
After impregnating the gauze with a solution containing X cation, it is hot rolled to dry and reinforce it. Combining aluminum-based minerals or aluminum-based mineral composites and sodium alginate suspensions, a stable cross-linking network structure is formed to improve gauze fibers and mineral materials. the bonding power.
The close combination of aluminum-based mineral or aluminum-based mineral composite materials and gauze fibers is achieved, which improves the stability and antibacterial effect of hemostatic gauze and reduces the occurrence of side effects.
Smart Images

Figure CN118903513A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of medical gauze, in particular to a high-stability multifunctional hemostatic gauze made of fiber composite aluminum-based minerals and a preparation method thereof. Background Art
[0002] The main forms of hemostatic materials include hemostatic gauze, hemostatic sponges and hydrogels. Hemostatic gauze is the most commonly used wound dressing in clinical practice. Compared with hydrogels and hemostatic sponges, hemostatic gauze is easy to use and has better environmental tolerance. It is economical and easy to mass produce and store. The preparation of gauze by combining inorganic hemostatic components with various fibers is considered to be an effective way to improve the hemostatic properties of inorganic materials and effectively expand their application scenarios. The preparation process of hemostatic gauze is to load the hemostatic active components (kaolin, zeolite and chitosan, etc.) on the surface of gauze fibers by physical impregnation. For example, QuikClot Combat combines kaolin and gauze through water immersion loading, and was approved by the US Food and Drug Administration for traumatic bleeding in 2013. The Chinese invention patent CN115463242A discloses a kaolin-based hemostatic gauze and its preparation method. The kaolin-based hemostatic gauze is prepared by water immersion, rolling and drying. The hemostatic gauze prepared by this process has a weak binding force between the hemostatic active component and the fiber, which causes the hemostatic active component to fall off easily during use, thereby causing side effects such as inflammation and thrombosis, which poses a great safety hazard. Therefore, the key to preparing a stable hemostatic gauze with no active component falling off is to optimize the formula. Summary of the invention
[0003] The purpose of the present invention is to address the above-mentioned deficiencies in the prior art and to provide a high-stability multifunctional hemostatic gauze made of fiber composite aluminum-based minerals and a preparation method thereof.
[0004] The invention discloses a method for preparing a fiber composite aluminum-based mineral high-stability multifunctional hemostatic gauze, comprising the steps of: dipping the gauze in a solution containing X cations and then drying; dipping the dried gauze loaded with X cations in a suspension of aluminum-based minerals or aluminum-based mineral composite materials and sodium alginate; and then drying and reinforcing the gauze through a hot rolling process to obtain the antibacterial hemostatic gauze; wherein X is one or more of Zn, Ca, Cu and Sr.
[0005] Furthermore, in the solution of X cations, the concentration of X cations is 0.1%wt-0.5%wt.
[0006] Furthermore, in the suspension, the mass ratio of the aluminum-based mineral or aluminum-based mineral composite material to sodium alginate is 1:0.3-0.6.
[0007] Furthermore, in the suspension, the concentration of sodium alginate is 0.3%wt-0.6%wt.
[0008] Furthermore, the aluminum-based mineral or aluminum-based mineral composite material is kaolin, zeolite, montmorillonite or a composite material thereof.
[0009] Furthermore, the gauze is non-woven fabric.
[0010] Furthermore, the base material of the gauze is cotton, polyester, polypropylene, polyester, polyethylene, viscose, silk, wool, rayon or their blended fibers.
[0011] Furthermore, the drying temperature is 60-80°C.
[0012] Furthermore, the dry-to-wet ratio of the antibacterial hemostatic gauze obtained by hot rolling drying and reinforcement is 20%.
[0013] An antibacterial hemostatic gauze prepared by the above-mentioned preparation method.
[0014] The present invention uses capillary force to pre-treat gauze fibers to load X cations, then prepares a suspension of sodium alginate and aluminum minerals or aluminum mineral composite materials, and uses a water immersion method to complete the preparation of antibacterial hemostatic gauze. When X cations are present, the Na on the G unit of sodium alginate + Ion exchange reaction occurs with divalent cations, and G units are stacked to form a robust cross-linked network structure. Sodium alginate reacts with divalent cations such as Cu 2+ , Sr. 2+ 、Zn 2+ , Ca 2+ And complexes that release such substances, such as ZnO, CaCO3, CaO, etc., are cross-linked to form stable gels, which improve the bonding force between aluminum-based minerals or aluminum-based mineral composites and gauze fibers, thereby achieving close bonding of aluminum-based minerals or aluminum-based mineral composites on gauze fibers, effectively solving the problem of mineral material shedding during the use of kaolin-based hemostatic gauze, and having high stability.
[0015] Sodium alginate has good biocompatibility. At the same time, in the process of hemostasis application, Ca 2+ The presence of Zn can effectively promote blood coagulation and achieve synergistic effects with aluminum minerals or aluminum mineral composites to achieve rapid hemostasis. 2+ The release of can achieve a good antibacterial effect and prevent wound infection. Multi-ion cross-linking has a good synergistic hemostatic effect, making the hemostatic gauze have good hemostatic and antibacterial effects. BRIEF DESCRIPTION OF THE DRAWINGS
[0016] Figure 1 Electron microscopic images of the SCZ-kaolin-based multifunctional hemostatic gauze prepared in Example 1 and a blank gauze;
[0017] Figure 2-1, 2-1 , 2-3 are the results of the cross-linking experiment;
[0018] Figure 3 is the result of the flexibility test;
[0019] Figure 4 , Figure 5 The results of ultrasonic peeling experiment;
[0020] Figure 6 The results of the hemolytic test;
[0021] Figure 7 Results of cytotoxicity experiments;
[0022] Figure 8 The results of the coagulation performance test;
[0023] Fig. 9 , Fig.10 The results of the liver hemostasis experiment;
[0024] Fig.11 The results of antibacterial experiments. DETAILED DESCRIPTION
[0025] The following are specific embodiments of the present invention and the accompanying drawings to further describe the technical solution of the present invention, but the present invention is not limited to these embodiments.
[0026] The preparation steps of kaolin-based aluminum-based minerals or aluminum-based mineral composite materials used in the following embodiments refer to Chinese invention patent 202211182898.X.
[0027] The preparation scheme of kaolin-based composite materials is as follows:
[0028] 1. Prepare FeOOH solution: Prepare 200 ml of 0.4 mol / L FeCl3 solution in a beaker, heat it to 70°C, and add 300 ml of 0.4 mol / L NaOH dropwise into the FeCl3 solution through a separatory funnel (forming a reddish-brown FeOOH precipitate). After the addition is complete, stir for 2 hours.
[0029] 2. Synthesis of FeOOH / Kaol: 10 g Kaol powder was added to 500 ml FeOOH solution, stirred at 70 °C for 2 h, then centrifuged at 8000 rpm, washed three times with water until neutral, dried in an oven at 60 °C, and crushed.
[0030] 3. Calcination: Calcine the dried and crushed FeOOH / Kaol in air at 250℃ for 1h, 350℃ for 1h, and 550℃ for 4h, then grind to ensure that the powder size is below 200 mesh, and obtain the product labeled as α-Fe2O3 / kaol
[0031] Example 1
[0032] Preparation process of SCZ-kaolin-based multifunctional hemostatic gauze:
[0033] In the first step, the non-woven fabric is immersed in a mixed suspension containing 0.1wt% ZnCl2, 0.2wt% CaCl2, and 0.4wt% ZnO in a stirring state, and then dried and rolled up. The gauze is marked as calcium zinc non-woven fabric; (the load ions and the complex can be selected from Cu 2+ , Sr. 2+ , CaCO3, CaO, etc. In this process, Zn 2+ , Ca 2+ (The non-woven fabric substrate can be selected from cotton, polyester, polypropylene, polyester, polyethylene, viscose, silk, wool, rayon, etc. or their blended fibers). The non-woven fabric substrate selected in this process is polyester fiber.
[0034] In the second step, α-Fe2O3 / Kaol and sodium alginate are prepared into a suspension according to a mass ratio of 1:0.5, and ultrasonic treatment is performed for 0.5h to uniformly disperse. The solvent is pure water, and air flow stirring is used to achieve uniform mixing of α-Fe2O3 / Kaol and sodium alginate.
[0035] In the third step, the calcium zinc nonwoven fabric prepared in the first step is immersed in a suspension of α-Fe2O3 / Kaol and sodium alginate in a stirring state, and then dried and reinforced by a hot rolling process, maintaining a dry-wet ratio of 20%. Then it is cut into pieces of 7.5cm×1.5m and 7.5cm×3.7m in size, folded in a Z shape, packaged, and sterilized to obtain a finished product marked as: SCZ-kaolin-based multifunctional hemostatic gauze.
[0036] Example 2
[0037] The mixed suspension of 0.1wt% ZnCl2, 0.2wt% CaCl2, and 0.4wt% ZnO in Example 1 was replaced with a suspension of 0.1wt% ZnCl2 and 0.4wt% ZnO, and the other processes remained unchanged to prepare SZ-kaolin-based multifunctional hemostatic gauze.
[0038] Example 3
[0039] The mixed suspension of 0.1wt% ZnCl2, 0.2wt% CaCl2, and 0.4wt% ZnO in Example 1 was replaced with a 0.2wt% CaCl2, 0.4wt% ZnO solution, and the other processes remained unchanged to prepare SZC-kaolin-based multifunctional hemostatic gauze.
[0040] Example 4
[0041] The mixed suspension of 0.1wt% ZnCl2, 0.2wt% CaCl2, and 0.4wt% ZnO in Example 1 was replaced with a 0.2wt% CuCl2, 0.4wt% ZnO solution, and the other processes remained unchanged to prepare SCU-kaolin-based multifunctional hemostatic gauze.
[0042] Example 5
[0043] The mixed suspension of 0.1wt% ZnCl2, 0.2wt% CaCl2, and 0.4wt% ZnO in Example 1 was replaced with a solution of 0.2wt% SrCl2, 0.2wt% CaCl2, and 0.4wt% ZnO, and the other processes remained unchanged to prepare SCR-kaolin-based multifunctional hemostatic gauze.
[0044] Example 6
[0045] The α-Fe2O3 / Kaol in Example 2 was replaced by montmorillonite, and the other processes remained unchanged to prepare SCZ-montmorillonite multifunctional hemostatic gauze.
[0046] Example 7
[0047] The α-Fe2O3 / Kaol in Example 2 was replaced by kaolin, and the other processes remained unchanged to prepare SCZ-kaolin multifunctional hemostatic gauze.
[0048] Example 8
[0049] The α-Fe2O3 / Kaol in Example 2 was replaced by zeolite, and the other processes remained unchanged to prepare SCZ-zeolite multifunctional hemostatic gauze.
[0050] Example 9
[0051] The polyester fiber in Example 1 was replaced with cotton, and the other processes remained unchanged to prepare antibacterial hemostatic gauze.
[0052] Comparative Example 1
[0053] Untreated blank nonwoven fabric, the base material is polyester;
[0054] Comparative Example 2
[0055] The commercially available kaolin first aid hemostatic dressing product was labeled as the commercially available kaolin hemostatic product for the control group;
[0056] Comparative Example 3
[0057] The calcium-zinc nonwoven fabric was immersed in a suspension of α-Fe2O3 / Kaol and chitosan (CS) in a mass ratio of 1:0.5 under stirring, and marked as CS-kaolin hemostatic gauze after drying.
[0058] Comparative Example 4
[0059] The calcium zinc nonwoven fabric was immersed in water in a suspension of α-Fe2O3 / Kaol and polyethylene glycol (PEG) in a mass ratio of 1:0.5 under stirring, and marked as PEG-kaolin hemostatic gauze after drying.
[0060] Comparative Example 5
[0061] The calcium-zinc nonwoven fabric was immersed in a suspension of α-Fe2O3 / Kaol and polyvinyl pyrrolidone (PVPK30) in a stirring state at a mass ratio of 1:0.5, and after drying, it was marked as PVP-kaolin hemostatic gauze.
[0062] Comparative Example 6
[0063] The calcium-zinc nonwoven fabric was immersed in a suspension of α-Fe2O3 / Kaol and polyvinyl alcohol (PVA) in a mass ratio of 1:0.5 under stirring, and after drying, it was marked as PVA-kaolin hemostatic gauze.
[0064] Comparative Example 7
[0065] The mass ratio of α-Fe2O3 / Kaol to sodium alginate in Example 1 was replaced by 1:1 according to 1:0.5, and the other processes remained unchanged to prepare SZC-kaolin-based multifunctional hemostatic gauze.
[0066] Comparative Example 8
[0067] The mass ratio of α-Fe2O3 / Kaol to sodium alginate in Example 1 was replaced by 1:0.5 to 1:0.7, and the other processes remained unchanged to prepare SZC-kaolin-based multifunctional hemostatic gauze.
[0068] Surface morphology analysis:
[0069] The surface of blank nonwoven fabric and SCZ-kaolin-based multifunctional hemostatic gauze was observed by scanning electron microscopy (SEM). Figure 1 As shown, smooth fibers can be seen on the surface of the blank non-woven fabric, and flaky kaolin-based hemostatic materials are evenly loaded on the surface of the SCZ-kaolin-based multifunctional hemostatic gauze.
[0070] Ionic crosslinking experiment:
[0071] SA, CS, PEG, PVP and PVA were mixed with Ca 2+ and Zn 2+ And mixed suspension Zn 2+ , Ca 2+ , ZnO cross-linking experiment, the experimental results are as follows Figure 2-1 , 2-2As shown in 2-3, only SA can cross-link with these divalent cations and substances that release these divalent cations, such as zinc oxide and calcium oxide, to form a stable water-insoluble gel. 2+ , Sr. 2+ 、Zn 2+ , Ca 2+ ) or substances (zinc oxide, calcium oxide) are introduced into the fiber surface, and the cross-linking combination of SA and α-Fe2O3 / Kaol suspension helps to form a highly stable water-insoluble coating on the fiber surface, thereby achieving stable and autonomous loading of kaolin inorganic minerals on the fiber surface, and preparing highly stable SCZ-kaolin-based multifunctional hemostatic gauze.
[0072] Flexibility test:
[0073] By continuously optimizing the process scheme, the SA, α-Fe2O3 / Kaol mixed suspension and Zn 2+ , Ca 2+ The concentration ratio between the ZnO ion suspension and the SCZ-kaolin-based multifunctional hemostatic gauze prepared at a higher mass ratio of α-Fe2O3 / Kaol and sodium alginate, such as 1:1 and 1:0.7, is brittle and has poor flexibility. By adjusting the ratio of α-Fe2O3 / Kaol and sodium alginate to a mass ratio of 1:0.5, the flexibility test results are as follows Figure 3 As shown, a SCZ-kaolin-based multifunctional hemostatic gauze with good flexibility was finally prepared, which effectively broadened the application scenarios of various hemostasis.
[0074] Ultrasonic peeling experiment:
[0075] The firmness of the SCZ-kaolin-based multifunctional hemostatic gauze binding to the fiber was evaluated by placing it in deionized water and ultrasonically treating it at different time intervals of 2, 4, 6, 8, and 10 minutes. The tightness of the binding of the kaolin hemostatic material to the gauze was tested, and then the sample was dried overnight at 60°C and weighed. The calculation formula of the residual mass ratio is as follows: residual mass ratio = (mass after washing - mass before washing) / mass before washing. The experimental results are shown in Figure 4 As shown in the figure, the residual mass ratio of SCZ-kaolin-based multifunctional hemostatic gauze after 10 minutes of ultrasonic treatment is 98.2%, while the residual mass ratio of commercially available kaolin hemostatic products after 10 minutes of ultrasonic treatment is 59.3%, and a large amount of kaolin hemostatic material on the surface falls off. The kaolin-based hemostatic material on the surface of SCZ-kaolin-based multifunctional hemostatic gauze is very tightly combined with the fiber, and the amount of kaolin hemostatic material falling off is extremely low. It performed well in the harsh ultrasonic stripping experiment, effectively solving the problem of mineral shedding in the previous kaolin-based hemostatic gauze, which was not tightly combined with the fiber.
[0076] The SCZ-kaolin-based multifunctional hemostatic gauze, CS-kaolin hemostatic gauze, PEG-kaolin hemostatic gauze, PVP-kaolin hemostatic gauze, and PVA-kaolin hemostatic gauze were placed in deionized water for ultrasonic treatment for 2 minutes, and the degree of tightness of the kaolin hemostatic material binding on the gauze was evaluated by observing the shedding of the kaolin hemostatic material in the reagent bottle. The experimental results are shown in Figure 5 As shown in the figure, the kaolin-based hemostatic material on the surface of CS-kaolin hemostatic gauze, PEG-kaolin hemostatic gauze, PVP-kaolin hemostatic gauze, and PVA-kaolin hemostatic gauze fell off severely, showing a brick-red suspension formed by the kaolin-based hemostatic material α-Fe2O3 / Kaol and water, while no shedding was found on the SCZ-kaolin-based multifunctional hemostatic gauze. This shows that the kaolin-based hemostatic material on the surface of the SCZ-kaolin-based multifunctional hemostatic gauze is tightly combined with the fiber.
[0077] Hemolytic test:
[0078] The hemolysis experiment was conducted using citrate rabbit blood. First, the citrate rabbit blood was centrifuged at 2500rpm for 5min, the red blood cells were separated by precipitation, and a 10% red blood cell suspension was prepared with phosphate buffer (PBS). Experimental steps: 5mg of gauze sample was added to 800μL PBS to prepare material solutions of different samples, mixed with 200μL of the prepared 10% red blood cell suspension, mixed and placed in a constant temperature of 37℃ for 2h. At the same time, a negative control group and a positive control group were set up. The negative control group must not have hemolysis. 800μL PBS was mixed with the prepared 200μL 10% red blood cell suspension; the positive control group must have hemolysis. 800μL deionized water was mixed with the prepared 200μL 10% red blood cell suspension. Three parallel experiments were set up for each sample. The mixed system after constant temperature incubation was centrifuged at 2500rpm for 10min, the supernatant was collected, and the absorbance OD value at a wavelength of 540nm was measured with an enzyme marker.
[0079] The experimental results are as follows Figure 6 As shown, the hemolysis rate of the blank non-woven fabric is 0.95%, and the hemolysis rate of the SCZ-kaolin-based multifunctional hemostatic gauze is only 1.21%, which is much less than 5%. It has a low hemolysis rate and exhibits good blood compatibility.
[0080] Cytotoxicity assay:
[0081] The experiment adopted the CCK-8 method and used human umbilical vein endothelial cells (HUVEC cells) as the research object to analyze the cytotoxicity of the samples. The experimental scheme is as follows: Use RPMI-1640 basic culture medium, 1% double antibody, and 10% fetal bovine serum to prepare a complete culture medium for culturing HUVEC cells. Take the normally frozen HUVEC cells and shake them continuously in a 37°C water bath environment until they are thawed. Pipette 1mL of HUVEC cell freezing solution and add it to a 15mL centrifuge tube with 10mL of complete culture medium. Shake to mix, centrifuge at 1000rpm for 5min, remove the supernatant and resuspend the cells with complete culture medium, and transfer the cell suspension to the culture dish. After the cells are cultured until they are in a good state of adherent growth, they are digested with trypsin to detach the cells from the adherent state and resuspend them. Adjust the density of the cell suspension to 1×10 per well. 4 The cells were inoculated in a 96-well plate at a cell density of 100 μL and incubated in a cell culture incubator at 37°C and 5% CO2 until the cells were well adhered to the wall and in production. The original culture medium was discarded, 100 μL of fresh complete culture medium was added to the control well, and 100 μL of culture medium containing samples of different concentrations was added to the test well. After adding the material, the cytotoxicity was determined after 24 and 48 hours of culture, that is, complete culture medium containing 10% CCK-8 reagent was added to each well, and the culture was continued for 1 hour. The absorbance OD value of the culture medium at 450nm was determined by an enzyme marker. At the same time, the wells without added sample materials were used as blank control groups, and the cell survival rate was calculated by measuring the absorbance. The cell survival rate was calculated as follows:
[0082] Cell viability = (OD 实验孔 -OD 空白孔 ) / (OD 对照孔 -OD 空白孔 )×100%
[0083] In this section, 1, 2, and 4 mg / mL concentration gradient samples were used for toxicity evaluation. The experimental results are shown in the following table. Figure 7 As shown, the cell survival rate of SCZ-kaolin-based multifunctional hemostatic gauze after 24h and 48h co-incubation was greater than 100%. αSCZ-kaolin-based multifunctional hemostatic gauze showed extremely low cytotoxicity and effectively promoted cell proliferation. In the cytotoxicity level, a cell survival rate greater than 75% is designated as reaching the first-level biosafety level. The test results show that SCZ-kaolin-based multifunctional hemostatic gauze reaches the first-level biosafety level and has good biocompatibility.
[0084] Coagulation performance test:
[0085] Sodium citrate rabbit whole blood was used for in vitro coagulation test. Calcium-supplemented whole blood (100 μL) was added to the specimen (10 mg) placed at the bottom of the test tube (negative control group, NC, sodium citrate whole blood (100 μL) without sample treatment; positive control, PC, 100 μL whole blood without sample treatment). After coagulation in a 37°C incubator for 3 minutes, deionized water (2 mL) was carefully added along the tube wall to terminate the reaction. The absorbance of hemoglobin of free red blood cells in the supernatant was measured at a wavelength of 540 nm using an enzyme marker. The coagulation index (BCI) was calculated by the following formula: BCI = OD sample / OD negative control × 100%. The higher the coagulation index, the slower the coagulation rate. The experimental results are as follows. Figure 8 As shown, SCZ-kaolin-based multifunctional hemostatic gauze has the lowest coagulation index and the fastest coagulation speed, and has good procoagulant performance.
[0086] Liver hemostasis test:
[0087] The hemostatic properties of the materials were evaluated by establishing a mouse liver model. Six-week-old female mice (25-30 g) were randomly divided into three groups of blank non-woven fabric, SCZ-kaolin-based multifunctional hemostatic gauze, and commercial kaolin hemostatic products. Each group had 5 mice and was anesthetized by intraperitoneal injection of 10% chloral hydrate. The rats were placed in a supine position, and the abdomen was disinfected with 70% ethanol and the skin was prepared. Sterile gauze was prepared in advance, and the initial weight of the gauze was measured using an electronic balance. The abdominal cavity was opened to find the right lobe of the liver and wrapped with sterile gauze. A bleeding wound with a length of 10 mm was made on the right lobe of the liver. Blank non-woven fabric, SCZ-kaolin-based multifunctional hemostatic gauze, and commercial kaolin hemostatic products were added. The three groups were respectively aspirated for the outflowing blood, and the timer was turned on at the same time to record the bleeding time of each group. When the liver bleeding in each group stopped completely, the timer was stopped, and the time at this time was the bleeding time of each group. The final weight of the sterile gauze and the corresponding materials in each group was measured, and the initial weight of each group was subtracted, which was the bleeding amount of each group.
[0088] The experimental results are as follows Fig. 9 , Fig.10 The hemostatic time of the SCZ-kaolin-based multifunctional hemostatic gauze is 62.8±6.1s and the bleeding volume is 80±41.8mg. These are much lower than the hemostatic time of the blank nonwoven fabric (212.6±15.6s) and the bleeding volume (404±84.7mg) and the hemostatic time of the commercially available kaolin hemostatic product (111.2±22.1s) and the bleeding volume (120±27.3mg). The results show that the SCZ-kaolin-based multifunctional hemostatic gauze has excellent hemostatic properties.
[0089] Antibacterial test:
[0090] The gram-negative bacteria and gram-positive bacteria were Escherichia coli (ATCC-25922) and Staphylococcus aureus (ATCC-25923), respectively. The bacterial colonies were dispersed in 5 mL of broth and shaken at 37 °C for 12 h. The bacterial solution was diluted (10 5~6 cfu mL -1 ). Prepare bacterial solution and add it to two different samples of SCZ-kaolin-based multifunctional hemostatic gauze and blank non-woven fabric to mix. Then put them into a constant temperature shaker at 180 rmin -1 The plate coating experiment was repeated three times in parallel. Fig.11 As shown in the figure, the antibacterial rates of SCZ-kaolin-based multifunctional hemostatic gauze against Escherichia coli and Staphylococcus aureus are 97.5% and 99.1%, respectively, which has a good antibacterial effect compared with the blank group and blank non-woven fabric.
[0091] For matters not mentioned above, the prior art applies.
[0092] Although some specific embodiments of the present invention have been described in detail through examples, those skilled in the art should understand that the above examples are for illustration only and are not intended to limit the scope of the present invention. Those skilled in the art to which the present invention belongs may make various modifications or supplements to the specific embodiments described or replace them in a similar manner, but they will not deviate from the direction of the present invention or exceed the scope defined by the attached claims. Those skilled in the art should understand that any modifications, equivalent substitutions, improvements, etc. made to the above embodiments based on the technical essence of the present invention should be included in the protection scope of the present invention.
Claims
1. A method for preparing a high-stability multifunctional hemostatic gauze of fiber composite aluminum minerals, characterized in that: The gauze is immersed in a solution containing X cations and then dried; the dried gauze loaded with X cations is then immersed in a suspension of aluminum minerals or aluminum mineral composite materials and sodium alginate, and then dried and reinforced by a hot rolling process to obtain an antibacterial hemostatic gauze; wherein X is one or more of Zn, Ca, Cu, and Sr.
2. The preparation method according to claim 1, characterized in that: In the solution of X cations, the concentration of X cations is 0.1%wt-0.5%wt.
3. The preparation method according to claim 1, characterized in that: In the suspension, the mass ratio of the aluminum series mineral or the aluminum series mineral composite material to the sodium alginate is 1:0.3-0.
6.
4. The preparation method according to claim 1, characterized in that: In the suspension, the concentration of sodium alginate is 0.3%wt-0.6%wt.
5. The preparation method according to claim 1, characterized in that: The aluminum series mineral is one or more of kaolin, zeolite and montmorillonite.
6. The preparation method according to claim 1, characterized in that: The gauze is non-woven fabric.
7. The preparation method according to claim 1, characterized in that: The base material of the gauze is cotton, polyester, polypropylene, polyester, polyethylene, viscose, silk, wool, rayon or their blended fibers.
8. The preparation method according to claim 1, characterized in that: The drying temperature is 60-80℃.
9. The preparation method according to claim 1, characterized in that: The dry-wet ratio of the antibacterial hemostatic gauze obtained by hot rolling drying and reinforcement is 20%.
10. A high-stability multifunctional hemostatic gauze made of fiber composite aluminum-based minerals prepared by the preparation method according to any one of claims 1 to 9.
Citation Information
Patent Citations
Hemostatic devices
CN104507507A
Preparation method for kaolin / calcium alginate film hemostatic antibacterial dressing with controllable surface roughness
CN109381733A
Non-woven hemostatic gauze as well as preparation method and application thereof
CN114748670A
Kaolin hemostatic gauze and preparation method thereof
CN115463242A
Modified carboxymethyl chitosan hemostatic material and preparation method thereof
CN115814149A
